Amdocs Stock Price, News & Analysis (NASDAQ:DOX)

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs declared a quarterly dividend on Wednesday, August 7th. Investors of record on Monday, September 30th will be given a dividend of $0.285 per share on Friday, October 25th. This represents a $1.14 annualized dividend and a yield of 1.72%. The ex-dividend date of this dividend is Friday, September 27th. View Amdocs' Dividend History.

Amdocs announced that its board has initiated a share buyback program on Thursday, November 9th 2017, which permits the company to repurchase $800,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company's board of directors believes its stock is undervalued.

Amdocs Limited (NASDAQ:DOX) issued its quarterly earnings data on Wednesday, August, 7th. The technology company reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.08. The technology company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Amdocs had a return on equity of 15.70% and a net margin of 9.90%. Amdocs's quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.03 earnings per share. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, November 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Amdocs issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $4.28-4.34 for the period, compared to the Thomson Reuters consensus estimate of $4.28. The company issued revenue guidance of $4.070233088-4.109981458 billion, compared to the consensus revenue estimate of $4.09 billion.

1 brokerages have issued twelve-month target prices for Amdocs' shares. Their forecasts range from $75.00 to $75.00. On average, they anticipate Amdocs' share price to reach $75.00 in the next year. This suggests a possible upside of 13.5% from the stock's current price. View Analyst Price Targets for Amdocs.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Amdocs.

Media coverage about DOX stock has trended somewhat positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Amdocs earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave news headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Amdocs.

Amdocs saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 2,390,000 shares, a drop of 9.1% from the August 30th total of 2,630,000 shares. Based on an average daily volume of 589,600 shares, the short-interest ratio is currently 4.1 days. Approximately 1.8% of the shares of the stock are short sold. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Cognizant Technology Solutions (CTSH), Wipro (WIT), Verisign (VRSN), NTT DATA CORP/ADR (NTDTY), Obic (OBIIF), EPAM Systems (EPAM), Aspen Technology (AZPN), Zscaler (ZS), GEMALTO NV/S (GTOMY), PROS (PRO), Endava (DAVA), Sogou (SOGO), Perficient (PRFT), Virtusa (VRTU) and Formula Systems (1985) (FORTY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include QUALCOMM (QCOM), Home Depot (hd), Activision Blizzard (ATVI), Alphabet (GOOG), Micron Technology (MU), AbbVie (ABBV), Boeing (BA), Caterpillar (CAT), Chevron (CVX) and Enterprise Products Partners (EPD).

Amdocs' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Robeco Institutional Asset Management B.V. (0.99%), Envestnet Asset Management Inc. (0.15%), Denali Advisors LLC (0.07%), Zurcher Kantonalbank Zurich Cantonalbank (0.05%), State of Alaska Department of Revenue (0.05%) and Bowling Portfolio Management LLC (0.02%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C., CenturyLink Investment Management Co, Denali Advisors LLC, Cerebellum GP LLC and Bowling Portfolio Management LLC.

DOX stock was purchased by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank , Robeco Institutional Asset Management B.V., Envestnet Asset Management Inc., State of Alaska Department of Revenue, Henry James International Management Inc., Arden Trust Co, Cerebellum GP LLC and Assenagon Asset Management S.A..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $66.10.

Amdocs has a market capitalization of $9.23 billion and generates $3.97 billion in revenue each year. The technology company earns $354.39 million in net income (profit) each year or $3.74 on an earnings per share basis. Amdocs employs 24,381 workers across the globe.View Additional Information About Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]